World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
55
Citations
11116
World Ranking
3813
National Ranking
1493

Overview

David M. Shlaes is affiliated with Case Western Reserve University in the United States. Their research primarily focuses on the fields of immunology and microbiology, with a particular emphasis on applied microbiology and biotechnology, economics and econometrics, molecular medicine, immunology, and complementary and alternative medicine.

The scientist's work covers several main topics, including antibiotic use and resistance, pharmaceutical economics and policy, antibiotic resistance in bacteria, biosimilars and bioanalytical methods, and complementary and alternative medicine studies.

David M. Shlaes has published papers in several prominent venues. The most frequent publication venues include:

  • ACS Infectious Diseases
  • Clinical Infectious Diseases

Recent published papers by David M. Shlaes include:

  • "Antibacterial Drugs: The Last Frontier," 2020, ACS Infectious Diseases
  • "Innovation, Nontraditional Antibacterial Drugs, and Clinical Utility," 2021, ACS Infectious Diseases
  • "Can Europe Pull It Together?", 2020, Clinical Infectious Diseases
  • "Personal View of the Antibiotic Value Proposition," 2020, ACS Infectious Diseases

Best Publications

  • Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: Guidelines for the Prevention of Antimicrobial Resistance in Hospitals

    David M. Shlaes;Dale N. Gerding;Joseph F. John;William A. Craig

  • Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy

    Joseph W. Chow;Michael J. Fine;David M. Shlaes;John P. Quinn

  • Transcription Profiling-Based Identification of Staphylococcus aureus Genes Regulated by the agr and/or sarA Loci

    P. M. Dunman;E. Murphy;S. Haney;D. Palacios

  • Ceftazidime-Resistant Klebsiella pneumoniae Isolates Recovered at the Cleveland Department of Veterans Affairs Medical Center

    Louis B. Rice;Elizabeth C. Eckstein;Jerome DeVente;David M. Shlaes

  • Diagnosis of nosocomial pneumonia in intubated, intensive care unit patients.

    R. A. Salata;M. M. Lederman;D. M. Shlaes;M. R. Jacobs

  • Infections due to Lancefield group C streptococci.

    Robert A. Salata;Phillip I. Lerner;David M. Shlaes;K. V. Gopalakrishna

  • Serogroup-Specific Epidemiology of Streptococcus pneumoniae: Associations with Age, Sex, and Geography in 7,000 Episodes of Invasive Disease

    J. A. G. Scott;A. J. Hall;R. Dagan;J. M. S. Dixon

  • The most frequent aminoglycoside resistance mechanisms--changes with time and geographic area: a reflection of aminoglycoside usage patterns? Aminoglycoside Resistance Study Groups.

    Unknown

  • Inducible, transferable resistance to vancomycin in Enterococcus faecalis A256

    Unknown

  • Clonal spread of vancomycin-resistant Enterococcus faecium between patients in three hospitals in two states.

    J W Chow;A Kuritza;D M Shlaes;M Green

  • Serious infections caused by Bacillus species

    Robert Sliman;Susan Rehm;David M. Shlaes

  • The FDA Reboot of Antibiotic Development

    David M. Shlaes;Dan Sahm;Carol Opiela;Brad Spellberg

  • Infections Due to Lancefield Group F and Related Streptococci (S. milleri, S. anginosus)

    David M. Shlaes;Phillip I. Lerner;Emanuel Wolinsky;K. V. Gopalakrishna

  • Enterococcal Bacteremia Without Endocarditis

    David M. Shlaes;Josef Levy;Emanuel Wolinsky

  • Decreased Teicoplanin Susceptibility of Methicillin-Resistant Strains of Staphylococcus aureus

    Jean Luc Mainardi;David M. Shlaes;David M. Shlaes;Richard V. Goering;Janet H. Shlaes;Janet H. Shlaes

  • Inducible resistance to vancomycin in Enterococcus faecium D366.

    Unknown

  • Vancomycin susceptibility and identification of motile enterococci.

    S Vincent;R G Knight;M Green;D F Sahm

  • Synergistic killing of vancomycin-resistant enterococci of classes A, B, and C by combinations of vancomycin, penicillin, and gentamicin.

    D M Shlaes;L Etter;L Gutmann

  • Comparative activities of the beta-lactamase inhibitors YTR 830, clavulanate, and sulbactam combined with ampicillin and broad-spectrum penicillins against defined beta-lactamase-producing aerobic gram-negative bacilli.

    M R Jacobs;S C Aronoff;S Johenning;D M Shlaes

  • Teicoplanin-resistant Staphylococcus aureus expresses a novel membrane protein and increases expression of penicillin-binding protein 2 complex.

    D M Shlaes;J H Shlaes;S Vincent;L Etter

  • White paper: Recommendations on the conduct of superiority and organism-specific clinical trials of antibacterial agents for the treatment of infections caused by drug-resistant bacterial pathogens

    Brad Spellberg;Eric P. Brass;John S. Bradley;Roger J. Lewis

  • Mechanism of action of the mannopeptimycins, a novel class of glycopeptide antibiotics active against vancomycin-resistant gram-positive bacteria.

    Alexey Ruzin;Guy Singh;Anatoly Severin;Youjun Yang

  • Further evidence that a cell wall precursor [C(55)-MurNAc-(peptide)-GlcNAc] serves as an acceptor in a sorting reaction.

    Alexey Ruzin;Anatoly Severin;Frank Ritacco;Keiko Tabei

  • Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals.

    David M. Shlaes;Dale N. Gerding;Joseph F. John;William A. Craig

  • DNA hybridization and contour-clamped homogeneous electric field electrophoresis for identification of enterococci to the species level.

    S. Donabedian;J. W.F Chow;D. M. Shlaes;M. Green

Frequent Co-Authors

Louis B. Rice
Louis B. Rice Brown University
Robert A. Bonomo
Robert A. Bonomo Case Western Reserve University
Robert A. Bonomo
Robert A. Bonomo Case Western Reserve University
Michael R. Jacobs
Michael R. Jacobs University Hospitals of Cleveland
Patricia A. Bradford
Patricia A. Bradford AstraZeneca (United Kingdom)
Robert A. Salata
Robert A. Salata Case Western Reserve University
Steven J. Projan
Steven J. Projan Rutgers, The State University of New Jersey
Michael M. Lederman
Michael M. Lederman Case Western Reserve University
William A. Craig
William A. Craig University of Wisconsin–Madison
Dale N. Gerding
Dale N. Gerding Veterans Health Administration

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in microbiology, exploring complementary online degrees can broaden career opportunities in healthcare, research, and public health. For example, many professionals pursue an online MPH programs easy to get into to gain expertise in public health management alongside their scientific background.

A microbiology degree can also serve as a foundation for roles in specialized healthcare fields. Those aiming to work with children might consider careers like becoming a child life specialist, which offers competitive roles and a strong child life specialist salary with bachelor degree.

For individuals with unique challenges, such as those with criminal records, selecting the best degree for felons can help them transition into careers in science and healthcare, including microbiology-related fields.

Additionally, microbiology graduates interested in nursing might explore pathways to become a functional medicine nurse practitioner, a role known for its holistic approach and favorable functional medicine nurse salary.

By combining microbiology with these complementary degrees and career paths, graduates can unlock diverse opportunities in research, healthcare, and beyond.

Best Scientists Citing David M. Shlaes

Trending Scientists